nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—chronic obstructive pulmonary disease	0.661	1	CbGaD
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—GSTP1—chronic obstructive pulmonary disease	0.0113	0.0729	CbGpPWpGaD
Auranofin—PRDX5—respiratory system—chronic obstructive pulmonary disease	0.0107	0.157	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00965	0.062	CbGpPWpGaD
Auranofin—PRDX5—connective tissue—chronic obstructive pulmonary disease	0.00943	0.138	CbGeAlD
Auranofin—PRDX5—bronchus—chronic obstructive pulmonary disease	0.00881	0.129	CbGeAlD
Auranofin—PRDX5—trachea—chronic obstructive pulmonary disease	0.00791	0.116	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00648	0.0416	CbGpPWpGaD
Auranofin—IKBKB—respiratory system—chronic obstructive pulmonary disease	0.00634	0.093	CbGeAlD
Auranofin—PRDX5—lung—chronic obstructive pulmonary disease	0.00569	0.0834	CbGeAlD
Auranofin—IKBKB—connective tissue—chronic obstructive pulmonary disease	0.00558	0.0819	CbGeAlD
Auranofin—IKBKB—bronchus—chronic obstructive pulmonary disease	0.00522	0.0766	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00511	0.0749	CbGeAlD
Auranofin—IKBKB—IKK complex recruitment mediated by RIP1—LY96—chronic obstructive pulmonary disease	0.0042	0.027	CbGpPWpGaD
Auranofin—IKBKB—Endogenous TLR signaling—LY96—chronic obstructive pulmonary disease	0.0042	0.027	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.00401	0.0257	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00341	0.0219	CbGpPWpGaD
Auranofin—IKBKB—lung—chronic obstructive pulmonary disease	0.00337	0.0494	CbGeAlD
Auranofin—Gingivitis—Tiotropium—chronic obstructive pulmonary disease	0.0033	0.0288	CcSEcCtD
Auranofin—Glossitis—Tiotropium—chronic obstructive pulmonary disease	0.00281	0.0245	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.00262	0.0168	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00261	0.0168	CbGpPWpGaD
Auranofin—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00234	0.0204	CcSEcCtD
Auranofin—Glossitis—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.0187	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.00213	0.0136	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00211	0.0184	CcSEcCtD
Auranofin—IKBKB—Type II diabetes mellitus—ADIPOQ—chronic obstructive pulmonary disease	0.00208	0.0133	CbGpPWpGaD
Auranofin—Melaena—Formoterol—chronic obstructive pulmonary disease	0.00204	0.0178	CcSEcCtD
Auranofin—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.0178	CcSEcCtD
Auranofin—IKBKB—Osteopontin Signaling—PLAU—chronic obstructive pulmonary disease	0.00199	0.0128	CbGpPWpGaD
Auranofin—IKBKB—Endogenous TLR signaling—TLR2—chronic obstructive pulmonary disease	0.00191	0.0122	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.00183	0.0118	CbGpPWpGaD
Auranofin—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.0154	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—IL17A—chronic obstructive pulmonary disease	0.00175	0.0113	CbGpPWpGaD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00172	0.011	CbGpPWpGaD
Auranofin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.0143	CcSEcCtD
Auranofin—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.0142	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.00154	0.0099	CbGpPWpGaD
Auranofin—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.0128	CcSEcCtD
Auranofin—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.0123	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—LY96—chronic obstructive pulmonary disease	0.00141	0.00905	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—LY96—chronic obstructive pulmonary disease	0.00135	0.00868	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—CTGF—chronic obstructive pulmonary disease	0.00132	0.0085	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—LY96—chronic obstructive pulmonary disease	0.00132	0.00848	CbGpPWpGaD
Auranofin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.0113	CcSEcCtD
Auranofin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.0111	CcSEcCtD
Auranofin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00127	0.0111	CcSEcCtD
Auranofin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.011	CcSEcCtD
Auranofin—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.0109	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.00124	0.00799	CbGpPWpGaD
Auranofin—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0106	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—LY96—chronic obstructive pulmonary disease	0.00122	0.00781	CbGpPWpGaD
Auranofin—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.0106	CcSEcCtD
Auranofin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.0105	CcSEcCtD
Auranofin—IKBKB—Osteopontin Signaling—MMP9—chronic obstructive pulmonary disease	0.00118	0.00758	CbGpPWpGaD
Auranofin—IKBKB—IKK complex recruitment mediated by RIP1—TLR4—chronic obstructive pulmonary disease	0.00118	0.00757	CbGpPWpGaD
Auranofin—IKBKB—Endogenous TLR signaling—TLR4—chronic obstructive pulmonary disease	0.00118	0.00757	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	0.00117	0.00754	CbGpPWpGaD
Auranofin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.0102	CcSEcCtD
Auranofin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0101	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—LY96—chronic obstructive pulmonary disease	0.00114	0.00735	CbGpPWpGaD
Auranofin—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00991	CcSEcCtD
Auranofin—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00991	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—SFTPD—chronic obstructive pulmonary disease	0.00113	0.00724	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00978	CcSEcCtD
Auranofin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00973	CcSEcCtD
Auranofin—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00972	CcSEcCtD
Auranofin—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00972	CcSEcCtD
Auranofin—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00111	0.0097	CcSEcCtD
Auranofin—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00943	CcSEcCtD
Auranofin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00938	CcSEcCtD
Auranofin—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00938	CcSEcCtD
Auranofin—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00935	CcSEcCtD
Auranofin—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00917	CcSEcCtD
Auranofin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00902	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—LY96—chronic obstructive pulmonary disease	0.00103	0.00662	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.00102	0.00654	CbGpPWpGaD
Auranofin—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00882	CcSEcCtD
Auranofin—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00882	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00101	0.00646	CbGpPWpGaD
Auranofin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00876	CcSEcCtD
Auranofin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.00814	CcSEcCtD
Auranofin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000934	0.00814	CcSEcCtD
Auranofin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000927	0.00807	CcSEcCtD
Auranofin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.00807	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.00092	0.00591	CbGpPWpGaD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000898	0.00577	CbGpPWpGaD
Auranofin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000895	0.0078	CcSEcCtD
Auranofin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000895	0.0078	CcSEcCtD
Auranofin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000873	0.00761	CcSEcCtD
Auranofin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000863	0.00752	CcSEcCtD
Auranofin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.00742	CcSEcCtD
Auranofin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00085	0.00741	CcSEcCtD
Auranofin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000845	0.00736	CcSEcCtD
Auranofin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00728	CcSEcCtD
Auranofin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00728	CcSEcCtD
Auranofin—IKBKB—EBV LMP1 signaling—CXCL8—chronic obstructive pulmonary disease	0.000827	0.00531	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000819	0.00526	CbGpPWpGaD
Auranofin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00713	CcSEcCtD
Auranofin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.00709	CcSEcCtD
Auranofin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000801	0.00698	CcSEcCtD
Auranofin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00079	0.00689	CcSEcCtD
Auranofin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00687	CcSEcCtD
Auranofin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000779	0.00678	CcSEcCtD
Auranofin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000775	0.00675	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—chronic obstructive pulmonary disease	0.000767	0.00492	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000756	0.00659	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000747	0.0048	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.000747	0.0048	CbGpPWpGaD
Auranofin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000734	0.0064	CcSEcCtD
Auranofin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000731	0.00637	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—HDAC2—chronic obstructive pulmonary disease	0.000722	0.00463	CbGpPWpGaD
Auranofin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000715	0.00623	CcSEcCtD
Auranofin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000693	0.00604	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000676	0.00434	CbGpPWpGaD
Auranofin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000671	0.00585	CcSEcCtD
Auranofin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000671	0.00584	CcSEcCtD
Auranofin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00572	CcSEcCtD
Auranofin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00572	CcSEcCtD
Auranofin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000654	0.0057	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000651	0.00418	CbGpPWpGaD
Auranofin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000643	0.0056	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR2—chronic obstructive pulmonary disease	0.00064	0.00411	CbGpPWpGaD
Auranofin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00556	CcSEcCtD
Auranofin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00556	CcSEcCtD
Auranofin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00543	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000621	0.00541	CcSEcCtD
Auranofin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.0054	CcSEcCtD
Auranofin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00538	CcSEcCtD
Auranofin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000617	0.00538	CcSEcCtD
Auranofin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00536	CcSEcCtD
Auranofin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00533	CcSEcCtD
Auranofin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00531	CcSEcCtD
Auranofin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00531	CcSEcCtD
Auranofin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00525	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR2—chronic obstructive pulmonary disease	0.000599	0.00385	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000597	0.00521	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000597	0.0052	CcSEcCtD
Auranofin—IKBKB—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.000596	0.00383	CbGpPWpGaD
Auranofin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00516	CcSEcCtD
Auranofin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00516	CcSEcCtD
Auranofin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00514	CcSEcCtD
Auranofin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00514	CcSEcCtD
Auranofin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.00512	CcSEcCtD
Auranofin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000583	0.00508	CcSEcCtD
Auranofin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00507	CcSEcCtD
Auranofin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000582	0.00507	CcSEcCtD
Auranofin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00506	CcSEcCtD
Auranofin—IKBKB—IL1-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.00058	0.00373	CbGpPWpGaD
Auranofin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00503	CcSEcCtD
Auranofin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00502	CcSEcCtD
Auranofin—IKBKB—EBV LMP1 signaling—TNF—chronic obstructive pulmonary disease	0.000576	0.0037	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—TNF—chronic obstructive pulmonary disease	0.000576	0.0037	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	0.000565	0.00363	CbGpPWpGaD
Auranofin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00488	CcSEcCtD
Auranofin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00485	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—TLR2—chronic obstructive pulmonary disease	0.000552	0.00355	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00055	0.00353	CbGpPWpGaD
Auranofin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.00478	CcSEcCtD
Auranofin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000548	0.00477	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—EDN1—chronic obstructive pulmonary disease	0.000543	0.00349	CbGpPWpGaD
Auranofin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000528	0.0046	CcSEcCtD
Auranofin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000528	0.0046	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR2—chronic obstructive pulmonary disease	0.000519	0.00334	CbGpPWpGaD
Auranofin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000517	0.0045	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	0.000517	0.00332	CbGpPWpGaD
Auranofin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00445	CcSEcCtD
Auranofin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00445	CcSEcCtD
Auranofin—IKBKB—Interleukin-1 signaling—IL1B—chronic obstructive pulmonary disease	0.00051	0.00327	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000502	0.00322	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.0005	0.00321	CbGpPWpGaD
Auranofin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00436	CcSEcCtD
Auranofin—IKBKB—NOD pathway—IL1B—chronic obstructive pulmonary disease	0.0005	0.00321	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.000499	0.0032	CbGpPWpGaD
Auranofin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00434	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—chronic obstructive pulmonary disease	0.000493	0.00317	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000483	0.0031	CbGpPWpGaD
Auranofin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000483	0.00421	CcSEcCtD
Auranofin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.0042	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000477	0.00306	CbGpPWpGaD
Auranofin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00413	CcSEcCtD
Auranofin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00413	CcSEcCtD
Auranofin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00047	0.0041	CcSEcCtD
Auranofin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.0041	CcSEcCtD
Auranofin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00409	CcSEcCtD
Auranofin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00409	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.000468	0.003	CbGpPWpGaD
Auranofin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000467	0.00407	CcSEcCtD
Auranofin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00405	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.000463	0.00297	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—MMP9—chronic obstructive pulmonary disease	0.000462	0.00297	CbGpPWpGaD
Auranofin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00401	CcSEcCtD
Auranofin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00401	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB2—chronic obstructive pulmonary disease	0.000453	0.00291	CbGpPWpGaD
Auranofin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000452	0.00394	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000451	0.00393	CcSEcCtD
Auranofin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.0039	CcSEcCtD
Auranofin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00387	CcSEcCtD
Auranofin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00387	CcSEcCtD
Auranofin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00386	CcSEcCtD
Auranofin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00386	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000437	0.0028	CbGpPWpGaD
Auranofin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00378	CcSEcCtD
Auranofin—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000434	0.00279	CbGpPWpGaD
Auranofin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00365	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000413	0.00265	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.000401	0.00258	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR4—chronic obstructive pulmonary disease	0.000395	0.00254	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000395	0.00254	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000386	0.00248	CbGpPWpGaD
Auranofin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00336	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KL—chronic obstructive pulmonary disease	0.00038	0.00244	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—TLR4—chronic obstructive pulmonary disease	0.000379	0.00244	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—chronic obstructive pulmonary disease	0.000373	0.0024	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.00037	0.00238	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000367	0.00236	CbGpPWpGaD
Auranofin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00318	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KL—chronic obstructive pulmonary disease	0.000363	0.00233	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000362	0.00233	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000356	0.00228	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000355	0.00228	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—TLR4—chronic obstructive pulmonary disease	0.000341	0.00219	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KL—chronic obstructive pulmonary disease	0.000336	0.00215	CbGpPWpGaD
Auranofin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000332	0.0029	CcSEcCtD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—chronic obstructive pulmonary disease	0.000331	0.00212	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.00033	0.00212	CbGpPWpGaD
Auranofin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00286	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000326	0.00209	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000322	0.00207	CbGpPWpGaD
Auranofin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.0028	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—chronic obstructive pulmonary disease	0.000321	0.00206	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000319	0.00205	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000308	0.00198	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—chronic obstructive pulmonary disease	0.000307	0.00197	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000289	0.00186	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.000289	0.00186	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000287	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—chronic obstructive pulmonary disease	0.000287	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000286	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB3—chronic obstructive pulmonary disease	0.000285	0.00183	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000285	0.00183	CbGpPWpGaD
Auranofin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00244	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000273	0.00175	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB3—chronic obstructive pulmonary disease	0.000272	0.00175	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000266	0.00171	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HDAC2—chronic obstructive pulmonary disease	0.000266	0.00171	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.00026	0.00167	CbGpPWpGaD
Auranofin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00225	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—chronic obstructive pulmonary disease	0.000257	0.00165	CbGpPWpGaD
Auranofin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00222	CcSEcCtD
Auranofin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00222	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00222	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—ERBB3—chronic obstructive pulmonary disease	0.000252	0.00162	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.000251	0.00161	CbGpPWpGaD
Auranofin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00219	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—KL—chronic obstructive pulmonary disease	0.000247	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000241	0.00155	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00209	CcSEcCtD
Auranofin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00209	CcSEcCtD
Auranofin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00203	CcSEcCtD
Auranofin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00202	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL1B—chronic obstructive pulmonary disease	0.00023	0.00148	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00023	0.00148	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000228	0.00146	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000222	0.00143	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000222	0.00143	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000222	0.00142	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	0.000219	0.0014	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—chronic obstructive pulmonary disease	0.000216	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000211	0.00135	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—chronic obstructive pulmonary disease	0.000211	0.00135	CbGpPWpGaD
Auranofin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00181	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000207	0.00133	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—chronic obstructive pulmonary disease	0.000204	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—chronic obstructive pulmonary disease	0.000204	0.00131	CbGpPWpGaD
Auranofin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00175	CcSEcCtD
Auranofin—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000199	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000198	0.00127	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.000196	0.00126	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000192	0.00124	CbGpPWpGaD
Auranofin—IKBKB—Immune System—LY96—chronic obstructive pulmonary disease	0.000192	0.00123	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.00019	0.00122	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.00019	0.00122	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000188	0.00121	CbGpPWpGaD
Auranofin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00163	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	0.000185	0.00119	CbGpPWpGaD
Auranofin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00161	CcSEcCtD
Auranofin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00161	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000181	0.00116	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—chronic obstructive pulmonary disease	0.00018	0.00116	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00018	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—chronic obstructive pulmonary disease	0.00018	0.00116	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000176	0.00113	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000176	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000175	0.00112	CbGpPWpGaD
Auranofin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00152	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—chronic obstructive pulmonary disease	0.000169	0.00108	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000163	0.00105	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000162	0.00104	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000162	0.00104	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000161	0.00103	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000159	0.00102	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000156	0.001	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000153	0.000984	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000153	0.000984	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000151	0.000967	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.00015	0.000962	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	0.000145	0.000928	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000143	0.00092	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000141	0.000906	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000141	0.000905	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000136	0.000876	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000135	0.000869	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	0.000135	0.000865	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000131	0.000841	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000131	0.000841	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	0.00013	0.000835	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.00013	0.000834	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000128	0.00082	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000126	0.000807	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000125	0.000801	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	0.000124	0.000795	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000123	0.000791	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	0.000122	0.000785	CbGpPWpGaD
Auranofin—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000122	0.000783	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.00012	0.000772	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	0.000118	0.000759	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000117	0.000753	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000115	0.000741	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000115	0.000735	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000114	0.000735	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.00011	0.000707	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—chronic obstructive pulmonary disease	0.000109	0.000702	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000109	0.0007	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000109	0.000699	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	0.000107	0.00069	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000106	0.000678	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000106	0.000678	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000104	0.000668	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000103	0.000664	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000101	0.000651	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	9.92e-05	0.000637	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.68e-05	0.000622	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—chronic obstructive pulmonary disease	9.66e-05	0.00062	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—chronic obstructive pulmonary disease	9.26e-05	0.000594	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	9.08e-05	0.000583	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	8.9e-05	0.000571	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR2—chronic obstructive pulmonary disease	8.73e-05	0.00056	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.69e-05	0.000558	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	8.44e-05	0.000542	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	8.39e-05	0.000539	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KL—chronic obstructive pulmonary disease	8.21e-05	0.000527	CbGpPWpGaD
Auranofin—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.08e-05	0.000519	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	8.05e-05	0.000517	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	8.02e-05	0.000515	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.01e-05	0.000514	CbGpPWpGaD
Auranofin—ALB—Metabolism—GC—chronic obstructive pulmonary disease	7.86e-05	0.000504	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.8e-05	0.000501	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.3e-05	0.000469	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—chronic obstructive pulmonary disease	6.61e-05	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	6.29e-05	0.000404	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.26e-05	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—chronic obstructive pulmonary disease	6.18e-05	0.000397	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB3—chronic obstructive pulmonary disease	6.15e-05	0.000395	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.82e-05	0.000374	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	5.81e-05	0.000373	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.73e-05	0.000368	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.71e-05	0.000366	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	5.63e-05	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—chronic obstructive pulmonary disease	5.62e-05	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—chronic obstructive pulmonary disease	5.39e-05	0.000346	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	5.33e-05	0.000342	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.31e-05	0.000341	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	5.17e-05	0.000332	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.9e-05	0.000314	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—chronic obstructive pulmonary disease	4.59e-05	0.000295	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	4.41e-05	0.000283	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.38e-05	0.000281	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.35e-05	0.00028	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.000276	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.000272	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.16e-05	0.000267	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.98e-05	0.000255	CbGpPWpGaD
Auranofin—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.83e-05	0.000246	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.56e-05	0.000228	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.53e-05	0.000226	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—chronic obstructive pulmonary disease	3.51e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.99e-05	0.000192	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.000191	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.79e-05	0.000179	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.75e-05	0.000176	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—chronic obstructive pulmonary disease	2.67e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.67e-05	0.000171	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000152	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	2.26e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.14e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—chronic obstructive pulmonary disease	2.05e-05	0.000132	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.92e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.76e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.73e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.45e-05	9.32e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.33e-05	8.53e-05	CbGpPWpGaD
